What is Zacks Research’s Forecast for Delek US Q1 Earnings?

Delek US Holdings, Inc. (NYSE:DK) – Analysts at Zacks Research decreased their Q1 2027 earnings per share (EPS) estimates for Delek US in a research report issued on Thursday, June 4th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings per share of ($0.31) for the quarter, down from their prior estimate of ($0.27). Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Delek US’s current full-year earnings is $4.96 per share. Zacks Research also issued estimates for Delek US’s Q4 2027 earnings at $0.64 EPS, FY2027 earnings at $1.23 EPS, Q1 2028 earnings at ($0.27) EPS and FY2028 earnings at ($0.27) EPS.

Delek US (NYSE:DK) last announced its earnings results on Wednesday, April 29th. The oil and gas company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of ($1.42) by $1.50. The company had revenue of $2.65 billion for the quarter, compared to analyst estimates of $2.33 billion. Delek US had a positive return on equity of 22.90% and a negative net margin of 0.48%.The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter last year, the company earned ($2.32) earnings per share.

DK has been the topic of a number of other research reports. Scotiabank raised Delek US to a “hold” rating in a research report on Friday, March 27th. Mizuho increased their price target on Delek US from $54.00 to $60.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 27th. Weiss Ratings downgraded Delek US from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Raymond James Financial increased their price target on Delek US from $47.00 to $54.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 25th. Finally, UBS Group increased their price target on Delek US from $42.00 to $48.00 and gave the stock a “neutral” rating in a research report on Friday, April 10th. Five analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $44.69.

Delek US Price Performance

Shares of NYSE DK opened at $48.36 on Monday. The firm has a market cap of $2.96 billion, a P/E ratio of -53.14, a price-to-earnings-growth ratio of 0.33 and a beta of 0.60. The company has a current ratio of 0.76, a quick ratio of 0.49 and a debt-to-equity ratio of 10.51. Delek US has a 1-year low of $18.94 and a 1-year high of $49.50. The business’s 50 day moving average is $43.85 and its 200-day moving average is $37.97.

Delek US Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 8th. Shareholders of record on Friday, May 1st were issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Friday, May 1st. Delek US’s dividend payout ratio (DPR) is currently -112.09%.

Insider Transactions at Delek US

In other Delek US news, EVP Reuven Spiegel sold 10,000 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $44.36, for a total value of $443,600.00. Following the sale, the executive vice president owned 48,372 shares of the company’s stock, valued at approximately $2,145,781.92. This trade represents a 17.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Vicky Sutil sold 1,871 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $48.00, for a total value of $89,808.00. Following the completion of the sale, the director directly owned 29,368 shares in the company, valued at approximately $1,409,664. This represents a 5.99% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 58,601 shares of company stock worth $2,631,960. 3.56% of the stock is owned by insiders.

Institutional Investors Weigh In On Delek US

Large investors have recently modified their holdings of the business. Brown Brothers Harriman & Co. acquired a new stake in shares of Delek US in the 3rd quarter valued at $27,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of Delek US by 95.6% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 884 shares of the oil and gas company’s stock valued at $26,000 after acquiring an additional 432 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Delek US by 173.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 968 shares of the oil and gas company’s stock valued at $29,000 after acquiring an additional 614 shares during the last quarter. Torren Management LLC bought a new position in shares of Delek US in the 4th quarter valued at $40,000. Finally, Focus Partners Wealth bought a new position in shares of Delek US in the 3rd quarter valued at $44,000. Institutional investors and hedge funds own 97.01% of the company’s stock.

About Delek US

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.